by Truveta staff | Nov 25, 2024 | Research
RSV-associated hospitalizations increased 191.5% throughout October 2024. RSV-associated hospitalizations also increased in vulnerable populations with a 233.3% in infants and young children (aged 0-4) and 137.0% increase in older adults (65+); 2.4% of all...
by Truveta staff | Nov 7, 2024 | Research
GLP-1 medications are revolutionizing the way we treat type 2 diabetes and obesity. First discovered forty years ago, GLP-1 receptor agonists were initially approved for type 2 diabetes in 2005, with the first weight-loss-specific approval following in 2014. Flash...
by Truveta staff | Nov 4, 2024 | Research
Citation: Shaukat, Aasma MD, MPH et al. Real-World Adherence to Repeat Testing for Stool-Based Non-Invasive Colorectal Cancer Screening Tests Among Individuals With Average Risk. The American Journal of Gastroenterology 119(10S):p S265-S266, October...
by Truveta staff | Oct 30, 2024 | Research
Truveta Research in collaboration with a Harvard Medical School researcher explore use of obesity treatments in youth before and after new comprehensive guidelines for obesity management were published by the American Academy of Pediatrics (AAP). In a study of 329,357...
by Truveta staff | Oct 28, 2024 | Research
Overall, the rate of hospitalizations associated with respiratory viruses decreased throughout September 2024 and into the first week of October. For infants and children aged 0-4 years old, respiratory virus-associated hospitalizations increased slightly by 2.9%...
by Truveta Research | Oct 25, 2024 | Research, Research Insights
For patients coming into the emergency department (ED) with nausea/vomiting or dehydration, patients are half as likely to receive IV fluids starting 10 days after the hurricane compared to prior to Hurricane Helene. We expect these numbers to continue to decrease. ...
